Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy

NCT00994266 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT00994266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00994266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy
Lead sponsor
Catalysis SL
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
April 30, 2011
Enrollment
116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes